IL9 and relapsing-remitting multiple sclerosis: The beneficial effect of IL-9 in MS disease was previously suggested in a clinical study where CSF levels of IL-9 have been negatively correlated with neurodegeneration, inflammatory activity and disease severity in RRMS patients [12], while information on progressive patients is missing.